P006 (0037) RECURRENT EXPORTIN 1 MUTATIONS IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA

P006 (0037) RECURRENT EXPORTIN 1 MUTATIONS IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA

Bibliographic Details
Format:	Article
Language:	English
Published:	Wiley 2018-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000547858.58890.8e

Similar Items

Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma
by: Mélody Caillot, et al.
Published: (2023-12-01)

T006 (0079) THE PERIPHERAL BLOOD NEUTROPHIL PD-L1 AND LYMPHOCYTE PD-1 AXIS IN CLASSICAL HODGKIN LYMPHOMA AT DIAGNOSIS
Published: (2018-10-01)

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience
by: Alberto Garaventa, et al.
Published: (2022-03-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)

Bob-1 is expressed in classic Hodgkin lymphoma
by: Abd El All Howayda S
Published: (2007-03-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma
by: Eline Boons, et al.
Published: (2015-09-01)

P006: Clinical outcome of classical Hodgkin Lymphoma patients receiving systemic anti-lymphoma treatment during SARS-COV-2 positivity: Results from the chemo-covid study on behalf of fondazione italiana linfomi
by: Chiara Rusconi, et al.
Published: (2022-10-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
by: Dennis A. Eichenauer, et al.
Published: (2018-10-01)

The Grey Zones of Classic Hodgkin Lymphoma
by: Jan Bosch-Schips, et al.
Published: (2022-01-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
by: Kumar Parimalam, et al.
Published: (2022-11-01)

P018 (0139) GATA3 EXPRESSION DISTINGUISHES CLASSIC HODGKIN LYMPHOMA FROM NODULAR LYMPHOCYTE HODGKIN LYMPHOMA
Published: (2018-10-01)

Therapeutic Targeting of Exportin-1 in Childhood Cancer
by: Basia Galinski, et al.
Published: (2021-12-01)

<i>XPO1</i><sup>E571K</sup> Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
by: Hadjer Miloudi, et al.
Published: (2020-09-01)

P007 (0043) TARC IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

P005 (0036) THE ROLE OF TCF3 IN CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

P014 (0098) CD47 IS EXPRESSED ON HODGKIN REED STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
by: Mikalai Katsin, et al.
Published: (2023-12-01)

Current directions in the treatment of classical Hodgkin lymphoma
by: Frank G. Keller, et al.
Published: (2023-11-01)

Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
by: Carmino Antonio de Souza, et al.
Published: (2023-10-01)

Bone marrow involvement by classic Hodgkin lymphoma
by: Mohammad Barouqa, et al.
Published: (2022-05-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
by: Soyoung Im, et al.
Published: (2022-11-01)

Relapsed and refractory classical Hodgkin lymphoma immunotherapy
by: Kirill Lepik
Published: (2020-10-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

Structural Basis of Targeting the Exportin CRM1 in Cancer
by: Achim Dickmanns, et al.
Published: (2015-09-01)

P048: Predictors of risk of relapse in classic Hodgkin lymphoma by flow cytometry
by: Jonathan Fromm, et al.
Published: (2022-10-01)

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma
by: Andrea Visentin, et al.
Published: (2022-10-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01)

P015 (0100) CHARACTERIZATION OF T-CELL PHENOTYPES WITH CLINICAL SIGNIFICANCE IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

P104 (0004) NIVOLUMAB IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA: EXPERIENCE WITH TEN PATIENTS
Published: (2018-10-01)

P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients
by: Rita Costa E. Sousa, et al.
Published: (2022-10-01)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
by: Hongyu Wang, et al.
Published: (2023-03-01)

Classical Hodgkin lymphoma following follicular lymphoma: a case report
by: Bomi Kim
Published: (2023-11-01)

Expression of GABPA and HO-1 in classical Hodgkin's lymphoma and their clinical significance
by: Hongling Li, et al.
Published: (2023-10-01)

Optimization of the first line treatment in classical Hodgkin's lymphoma
by: Pauline Brice
Published: (2018-06-01)

Classic Hodgkin lymphoma-nodular sclerosis – case report
by: Mihaela Lebedenco, et al.
Published: (2023-06-01)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
by: Vincent Camus, et al.
Published: (2021-03-01)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
by: Timothy J Voorhees, et al.
Published: (2020-10-01)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
by: Diede A. G. van Bladel, et al.
Published: (2022-06-01)

The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
by: Nicholas Meti, et al.
Published: (2018-06-01)